NCT06043713 2025-12-19Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V MutationsFred Hutchinson Cancer CenterPhase 1 Recruiting24 enrolled